Shares of Globus Medical rose after the company issued preliminary fourth-quarter sales numbers and a 2026 outlook that both beat analysts' expectations. The stock gained 10% to $99.74 in after-hours ...
According to MarketsandMarkets, the report "Flexible Plastic Bags Packaging Market by Application (Food, Beverages, Pharmaceutical & healthcare) ...
Pharma marketers enter 2026 asking where DTC fits in the DTP era. That question, which few foresaw 12 months ago, reflects the fast rise of direct-to-patient (DTP) programs. In the last few months ...
Pfizer said revenue should come in at the lower end of its guidance for this year, while it expects less revenue in 2026 than in 2025, as the drugmaker’s efforts to remake its business continue to ...
CGTN Europe interviewed Matt Maley, Chief Market Strategist, Miller Tabak + Co., LLC Morrisons loses £17m court battle over rotisserie chicken Ukraine-Russia war latest: Moscow refuses to give up land ...
Another wave of winter weather is expected to bring snow and sleet to Ohio starting around Dec. 10. The Cincinnati and Chardon areas could see the most snow, with forecasts predicting up to 7 inches.
Macy’s raised its sales forecast for the year after strong results at its upscale chain, highlighting how higher-income consumers continue to spend relatively freely. By Jenny Gross Macy’s, the ...
UroGen Pharma (URGN) is rated a Strong Buy, with a $33/share price target by end of 2026, driven by its proprietary RTGel technology. URGN's newly approved Zusduri targets a large bladder cancer ...
AUSTIN (KXAN) — We’re less than a week away from the start of meteorological winter, which runs from Dec. 1 through Feb. 28. The preliminary outlook for December from the Climate Prediction Center ...
US retail sales slowed in September as investors got the first official glimpse of consumer spending in two months on Tuesday morning after the government shutdown halted a wide swath of economic data ...
Hosted on MSN
Tonix Pharma Amends Sales Agreement to Raise Capital
Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results